Clinical Trial Update: Memory Impairment Study (Mild Cognitive Impairment Study) [Phase 3]

View source ↗

Summary

A Phase 3 memory impairment study (Mild Cognitive Impairment) sponsored by the National Institute on Aging for Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Alzheimer Disease | Phase 3 | Status: COMPLETED